Vasomotor regulation of coronary microcirculation by oxidative stress: role of arginase.

作者: Lih Kuo , Travis W. Hein

DOI: 10.3389/FIMMU.2013.00237

关键词: PharmacologyEndotheliumImmunologyNitric oxideVasomotorReactive oxygen speciesPeroxynitriteMicrocirculationMedicineArginaseOxidative stress

摘要: Overproduction of reactive oxygen species, i.e., oxidative stress, is associated with the activation redox signaling pathways linking to inflammatory insults and cardiovascular diseases by impairing endothelial function consequently blood flow dysregulation due microvascular dysfunction. This review focuses on regulation vasomotor in coronary microcirculation nitric oxide (NO) during stress inflammation related L-arginine consuming enzyme arginase. Superoxide produced vascular wall compromises not only scavenging endothelium-derived NO but also inhibiting prostacyclin synthesis formation peroxynitrite. The upregulation arginase contributes deficiency dysfunction various initiating or following inflammation. Hydrogen peroxide, a diffusible stable oxidizing agent, exerts vasodilator plays important roles physiological flow. In occlusive ischemia, release hydrogen peroxide from microvasculature helps restore collateral microvessels exercise training. However, excessive production prolonged exposure impairs NO-mediated reducing availability through hydroxyl radical-dependent can be double-edged sword microcirculation, which tissue survival one way improving elicits injury other causing impact development angiotensin II receptor activation, hypertension, ischemia-reperfusion, hypercholesterolemia discussed.

参考文章(160)
Zvonimir S. Katusic, Vascular endothelial dysfunction: does tetrahydrobiopterin play a role? American Journal of Physiology-heart and Circulatory Physiology. ,vol. 281, ,(2001) , 10.1152/AJPHEART.2001.281.3.H981
WEI WANG, TRAVIS W. HEIN, CUIHUA ZHANG, DAVID C. ZAWIEJA, JAMES C. LIAO, LIH KUO, Oxidized low-density lipoprotein inhibits nitric oxide-mediated coronary arteriolar dilation by up-regulating endothelial arginase I. Microcirculation. ,vol. 18, pp. 36- 45 ,(2011) , 10.1111/J.1549-8719.2010.00066.X
S Chandra, MJ Romero, A Shatanawi, AM Alkilany, RB Caldwell, RW Caldwell, Oxidative species increase arginase activity in endothelial cells through the RhoA/Rho kinase pathway British Journal of Pharmacology. ,vol. 165, pp. 506- 519 ,(2012) , 10.1111/J.1476-5381.2011.01584.X
Hany M El-Bassossy, Rania El-Fawal, Ahmed Fahmy, Malcolm L Watson, Arginase inhibition alleviates hypertension in the metabolic syndrome British Journal of Pharmacology. ,vol. 169, pp. 693- 703 ,(2013) , 10.1111/BPH.12144
Inge de Lepeleire, Marleen Depré, Kathleen Wynants, Anne van Hecken, Agnes Buntinx, Jef Arnout, Barry J. Gertz, David L. Ebel, Aimee Dallob, Peggy H. Wong, Jules I. Schwartz, Wesley Tanaka, Paul J. de Schepper, Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers. The Journal of Clinical Pharmacology. ,vol. 40, pp. 1109- 1120 ,(2000) , 10.1177/009127000004001005
Haroldo A Toque, Maritza J Romero, Rita C Tostes, Alia Shatanawi, Surabhi Chandra, Zidonia N Carneiro, Edward W Inscho, Robert Clinton Webb, Ruth B Caldwell, Robert William Caldwell, None, p38 Mitogen‐Activated Protein Kinase (MAPK) Increases Arginase Activity and Contributes to Endothelial Dysfunction in Corpora Cavernosa from Angiotensin‐II‐Treated Mice The Journal of Sexual Medicine. ,vol. 7, pp. 3857- 3867 ,(2010) , 10.1111/J.1743-6109.2010.01996.X
GR Heyndrickx, DH Boettcher, SF Vatner, Effects of angiotensin, vasopressin, and methoxamine on cardiac function and blood flow distribution in conscious dogs. American Journal of Physiology. ,vol. 231, pp. 1579- 1587 ,(1976) , 10.1152/AJPLEGACY.1976.231.5.1579
S. Evans Downing, Edmund H. Sonnenblick, Effects of continuous administration of angiotensin II on ventricular performance Journal of Applied Physiology. ,vol. 18, pp. 585- 592 ,(1963) , 10.1152/JAPPL.1963.18.3.585
Michel Félétou, Yu Huang, Paul M Vanhoutte, Endothelium-mediated control of vascular tone: COX-1 and COX-2 products British Journal of Pharmacology. ,vol. 164, pp. 894- 912 ,(2011) , 10.1111/J.1476-5381.2011.01276.X